Jeffrey Skolnik, MD on INO-5401 in Combination with PD-1 Inhibitor Libtayo @InovioPharma

Jeffrey Skolnik, MD on INO-5401 in Combination with PD-1 Inhibitor Libtayo @InovioPharma

Cancer-News

1 month
12 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Jeffrey Skolnik, MD of INOVIO Pharmaceuticals @InovioPharma discusses INO-5401 in combination with PD-1 inhibitor libtayo (cemiplimab) demonstrates 85% of newly diagnosed glioblastoma patients are alive 12 months following treatment.

Read here: http://s23.q4cdn.com/479936946/files/doc_news/INOVIOs-INO-5401-in-Combination-with-PD-1-Inhibitor-Libtayo-cemiplimab-Demonstrates-85-of-Newly-Diagnosed-Glioblastoma-Patients-Are-A-5VT78.pdf

Up Next Autoplay